Hugh Mostafid
Papers
1
Total Citations
156
H-Index
1
About
Dr. Hugh Mostafid is a distinguished urological surgeon whose research has profoundly shaped the management of upper tract urothelial carcinoma (UTUC). His primary focus lies in advancing surgical oncology, particularly through rigorous comparative effectiveness studies. Mostafid’s landmark contribution is his 2017 European Association of Urology (EAU) Guidelines systematic review, which critically evaluated oncological outcomes of laparoscopic versus open radical nephroureterectomy for UTUC. This work, cited over 150 times, provided pivotal evidence that helped standardize surgical approaches and informed international clinical guidelines. Beyond this, his research consistently emphasizes evidence-based practice, patient safety, and the integration of novel technologies into urological care. A key figure in the EAU Guidelines Office, Mostafid’s work has directly influenced how surgeons worldwide treat complex urological cancers. His dedication to high-quality, reproducible research has made him a trusted voice in the field, bridging the gap between surgical innovation and clinical reality. For students and researchers, Mostafid exemplifies how systematic, methodical investigation can drive meaningful change in patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1